Scientists have reportedly administered an AI-designed virus to a human patient for the first time in an experimental effort to treat a serious bacterial infection that no longer responds to antibiotics.
According to California-based AI company Radical Numerics, the patient received an experimental treatment involving a virus designed with the assistance of the company’s AI model, Omni-1.
The model is designed to create bacteriophages — viruses that target specific bacteria and can destroy them without harming human cells.
AI Aims to Improve Bacteriophage Therapy
Doctors have already been exploring bacteriophage therapy as an experimental treatment for severe bacterial infections, particularly in cases where conventional antibiotics and other treatment options have become ineffective.
Traditionally, researchers search for naturally occurring phages capable of attacking the harmful bacteria responsible for a patient’s infection. The reported AI-assisted approach goes a step further by redesigning part of the virus to help it recognize and attack specific disease-causing bacteria more effectively.
According to the company, artificial intelligence could eventually reduce the process of developing suitable viruses to just a few days, potentially speeding up the search for treatments against difficult-to-treat bacterial infections.
Treatment Provided Under Special Medical Programme
The report said the patient received the experimental treatment through a special medical programme that allows doctors to offer unconventional and investigational therapies when standard treatments have failed.
While the reported case highlights a potential new application of artificial intelligence in medicine, the available report does not provide details about the patient’s response to treatment or establish whether the therapy was successful.
The development underscores growing interest in AI-assisted drug and treatment design, particularly as antibiotic resistance makes some bacterial infections increasingly difficult to manage.